Flow cytometric analysis of DNA content in human ovarian cancers
1989

DNA Content Analysis in Ovarian Cancer

Sample size: 155 publication Evidence: moderate

Author Information

Author(s): E. Erba, P. Ubezio, S. Pepe, M. Vaghi, S. Marsoni, W. Torri, C. Mangioni, F. Landoni, M. D'Incalci

Primary Institution: Istituto di Ricerche Farmacologiche 'Mario Negri'

Hypothesis

The study investigates the relationship between DNA content and clinical features in ovarian cancer.

Conclusion

The study found that DNA aneuploid tumours are more common in advanced stages of ovarian cancer and are associated with poorer differentiation.

Supporting Evidence

  • 34 samples were DNA diploid tumours, while 121 were DNA aneuploid tumours.
  • Stages III and IV were more likely to be DNA aneuploid.
  • Patients with residual tumour size >2cm had more DNA aneuploid tumours.
  • Poorly differentiated tumours were more likely to be DNA aneuploid.

Takeaway

Doctors looked at the DNA of cancer cells from 101 women with ovarian cancer to see how it relates to the cancer's severity. They found that more advanced cancers often had different DNA than less severe ones.

Methodology

Flow cytometric analysis was performed on 155 specimens from 101 ovarian carcinoma patients to evaluate DNA content and cell cycle phases.

Potential Biases

Potential bias due to the predominance of normal cells in samples analyzed by flow cytometry.

Limitations

The study's sample size was relatively small, which may limit the generalizability of the findings.

Participant Demographics

101 patients with ovarian cancer, 30 of whom had received chemotherapy.

Statistical Information

P-Value

p<0.01

Confidence Interval

95% confidence limits 44-79

Statistical Significance

p<0.01

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication